Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2024-10-16
Summary
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Conditions
- Down Syndrome
- Fetal Aneuploidy
Sponsors & Collaborators
-
Sequenom, Inc.
lead INDUSTRY
Principal Investigators
-
Daniel Grosu, MD · Sequenom, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2025-12-31
- Completion
- 2026-03-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Prenatal Screening for Down Syndrome With DNAFirst
NCT01966991 ·Status: COMPLETED
-
Whole Blood Specimen Collection From Pregnant Subjects
NCT02430584 ·Status: UNKNOWN
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT00847990 ·Status: COMPLETED
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
NCT02255825 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393 ·Status: COMPLETED
-
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334 ·Status: COMPLETED
-
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399 ·Status: COMPLETED
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
Automated Screen for Fetal Aneuploidy
NCT03635359 ·Status: UNKNOWN
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Development of New Prenatal Diagnostic Tests From Maternal Blood
NCT00314691 ·Status: TERMINATED ·Phase: NA
-
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
NCT06690099 ·Status: RECRUITING
-
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
NCT00064597 ·Status: UNKNOWN
-
Multiple Gestation Study
NCT02278536 ·Status: COMPLETED
-
Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
NCT01708746 ·Status: COMPLETED
-
Down Syndrome Screening Based on Dried Blood Spots and Cell-free Fetal DNA
NCT01837979 ·Status: UNKNOWN
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
NCT02991729 ·Status: COMPLETED ·Phase: NA
-
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
NCT03831256 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA